Reorganization of enhancer patterns in transition from naive to primed pluripotency C Buecker, R Srinivasan, Z Wu, E Calo, D Acampora, T Faial, A Simeone, ... Cell stem cell 14 (6), 838-853, 2014 | 499 | 2014 |
Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activities B Crosas, J Hanna, DS Kirkpatrick, DP Zhang, Y Tone, NA Hathaway, ... Cell 127 (7), 1401-1413, 2006 | 368 | 2006 |
Enhancers as information integration hubs in development: lessons from genomics C Buecker, J Wysocka Trends in Genetics 28 (6), 276-284, 2012 | 333 | 2012 |
A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells C Buecker, HH Chen, JM Polo, L Daheron, L Bu, TS Barakat, P Okwieka, ... Cell stem cell 6 (6), 535-546, 2010 | 272 | 2010 |
Pluripotent state transitions coordinate morphogenesis in mouse and human embryos MN Shahbazi, A Scialdone, N Skorupska, A Weberling, G Recher, M Zhu, ... Nature 552 (7684), 239-243, 2017 | 231 | 2017 |
Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells R Samuel, L Daheron, S Liao, T Vardam, WS Kamoun, A Batista, ... Proceedings of the National Academy of Sciences 110 (31), 12774-12779, 2013 | 183 | 2013 |
DAZL limits pluripotency, differentiation, and apoptosis in developing primordial germ cells HH Chen, M Welling, DB Bloch, J Muñoz, E Mientjes, X Chen, C Tramp, ... Stem cell reports 3 (5), 892-904, 2014 | 105 | 2014 |
Temporal dissection of an enhancer cluster reveals distinct temporal and functional contributions of individual elements HF Thomas, E Kotova, S Jayaram, A Pilz, M Romeike, A Lackner, T Penz, ... Molecular Cell 81 (5), 969-982. e13, 2021 | 61 | 2021 |
Different flavors of pluripotency, molecular mechanisms, and practical implications C Buecker, N Geijsen Cell stem cell 7 (5), 559-564, 2010 | 52 | 2010 |
An ES-like pluripotent state in FGF-dependent murine iPS cells B Di Stefano, C Buecker, F Ungaro, A Prigione, HH Chen, M Welling, ... PLoS One 5 (12), e16092, 2010 | 26 | 2010 |
NMD is required for timely cell fate transitions by fine-tuning gene expression and regulating translation M Huth, L Santini, E Galimberti, J Ramesmayer, F Titz-Teixeira, R Sehlke, ... Genes & Development 36 (5-6), 348-367, 2022 | 21 | 2022 |
Methods and compositions for homologous recombination in human cells N Geijsen, C Buecker US Patent 8,524,498, 2013 | 12 | 2013 |
Transient upregulation of IRF1 during exit from naive pluripotency confers viral protection M Romeike, S Spach, M Huber, S Feng, G Vainorius, U Elling, ... EMBO reports 23 (9), e55375, 2022 | 6 | 2022 |
What is an enhancer? HF Thomas, C Buecker Bioessays 45 (10), 2300044, 2023 | 4 | 2023 |
iPSCs: 10 years and counting SK Kim, K Baldwin, S Gao, C Bücker, M Parmar, N Benvenisty Cell 165 (5), 1041-1042, 2016 | 3 | 2016 |
The asynchrony in the exit from naive pluripotency cannot be explained by differences in the cell cycle phase S Jayaram, M Romeike, C Buecker bioRxiv, 2023.09. 15.557731, 2023 | 2 | 2023 |
NMD is required for timely cell fate transitions by fine-tuning gene expression and controlling translation E Galimberti, R Sehlke, M Huth, M Garmhausen, M Romeike, ... bioRxiv, 2020.07. 07.180133, 2020 | 1 | 2020 |
Detailed temporal dissection of an enhancer cluster reveals two distinct roles for individual elements H Thomas, E Kotova, A Pilz, M Romeike, A Lackner, C Bock, M Leeb, ... bioRxiv, 2020.05. 06.080564, 2020 | 1 | 2020 |
Erratum: Pluripotent state transitions coordinate morphogenesis in mouse and human embryos MN Shahbazi, A Scialdone, N Skorupska, A Weberling, G Recher, M Zhu, ... Nature 555 (7694), 126-126, 2018 | 1 | 2018 |
Methods and compositions for homologous recombination in human cells N Geijsen, C Buecker US Patent App. 13/968,852, 2014 | 1 | 2014 |